SK pharmteco Reaffirms Three-Business-Unit Strategy, Strengthens Global Gene Therapy Business Unit with Funding Commitment
SK pharmteco reaffirms its three business unit strategy - small molecules, peptides, and viral vectors - with $100 million funding commitment.
SP
sk pharmteco inc.
via Globe Newswire
Updated 2h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Walsall selected as one of six systems to lead national Creative Health programme
Next

